New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
08:21 EDTMYOSMYOS receives patent allowance in U.S.
MYOS announced that it recently received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Serial No. 13/765,340 covering the Company's proprietary methods of manufacturing Fortetropin, the first clinically proven natural myostatin inhibitor. Upon issuance, the U.S. Patent entitled, "Process for Producing a Composition Containing Active Follistatin," will provide intellectual property protection for making the key ingredient in MYOS' core commercial muscle health products and carries a patent term through early 2033.
News For MYOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MYOS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use